GLP-1 RAs Reduce Suicidal Behavior in Adolescents
Study found a 33% drop in suicidal ideation and attempts, with effect lasting up to 3 years. Medscape Medical News
Does BMI Underestimate Breast Cancer Risk?
Hormone receptor stratification showed that differences in population-attributable risk fractions by body fat were only observed in hormone receptor–positive cases. Medscape Medical News
Two women talk about their diagnoses during breast cancer awareness month to inspire others
October is breast cancer awareness month and highlights a troubling increase of diagnoses in women under 50. Early Today’s Fredlyn Pierre Louis spoke with two women who wanted to share
Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy
1. In a cohort of individuals with invasive ductal carcinoma (IDC) that underwent breast-conserving surgery (BCS) and adjuvant breast radiotherapy, the use of statins was associated with a decreased risk
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
Around 40% of postmenopausal hormone positive breast cancer cases may be linked to excess body fat, suggests Spanish research published online in the Journal of Epidemiology & Community Health.
Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancer
(MedPage Today) — The obesity epidemic may be plateauing in the U.S.; this could be why. (Washington Post)
A cohort study of older adults with an initial fragility fracture
Distant Recurrence Risk in Early Breast Cancer on the Decline
(MedPage Today) — The long-term risk of distant recurrence for women with early breast cancer has declined significantly, a decades-long analysis of clinical trial data showed, largely a result of
FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national
The importance of breast cancer screening
October is Breast Cancer Awareness Month. Breast cancer is the second-leading cause of cancer deaths in women across the U.S. And rates of the disease continue to climb, notably among
Experimental drug RK-33 shows promise in treating breast cancer bone metastasis
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33
Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage
The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.
Study Suggests No Suicide Signal in Teens Prescribed GLP-1 Agonists
(MedPage Today) — Treatment with GLP-1 receptor agonists was associated with lower risks of suicidal ideation or attempts in adolescents with obesity compared with those who were treated with lifestyle
GLP-1 weight-loss meds won’t raise teens’ suicide risk, may even lower it
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide
New way to kill cancer cells could lead to longer lasting protection for people with breast cancer
Killing breast cancer cells in a way that trains the immune system to recognize and destroy residual cancer cells could offer longer lasting protection to people with the disease.
Jill Martin urges awareness of breast cancer genetic testing on ‘Football Night in America’
TODAY contributor Jill Martin was diagnosed Stage 2 breast cancer in 2023 after she learned she had a BRCA gene mutation, which increases a woman’s risk of developing breast cancer
How to decide which breast cancer surgery is right for you
Women diagnosed with breast cancer are almost immediately confronted with treatment decisions. If a surgical oncologist gave a choice between a lumpectomy and a mastectomy to remove a tumor, that’s
Cheap Ozempic knock-offs have risen in popularity — but are they safe?
As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Dr. Brett Osborn and Dr. Sue Decotiis warn
Novel procedure combined with semaglutide may eliminate insulin dependency in type 2 diabetes
Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.
‘I’m a radiologist — to reduce breast cancer risk, eat these 5 foods and follow these healthy habits’
Fox News medical contributor Dr. Nicole Saphier appeared on “Fox & Friends” on Sunday to discuss the rising risk of breast cancer — and specific foods and habits that can
Kristen Dahlgren, Miranda McKeon share their breast cancer journey
Two breast cancer survivors, former NBC Correspondent Kristen Dahlgren and actor Miranda McKeon, join TODAY to talk about their experiences with breast cancer and the race for a vaccine for
Dense breasts can make it harder to spot cancer on a mammogram
A new U.S. rule requires mammography centers to inform women about their breast density
Doctor answers common breast cancer, mammogram questions
According to breastcancer.org, one in eight women in the U.S. will develop breast cancer at some point in their lifetime. However, the type is considered one of the most curable
Combination therapy shows promise against triple-negative breast cancer
GLP-1 drugs like Ozempic may protect brain health, several studies show
YouTube content can help some people cope with breast cancer diagnosis, Spanish study finds
A study by the University of the Basque Country (UPV/EHU) has identified the most relevant YouTube videos on breast cancer and the concerns of the people who post comments. The
Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says
Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s designed to work differently from those currently on the market and
Metabolic-Bariatric Surgery Reduces Pancreatic Cancer Risk
Effect appeared more pronounced among those with type 2 diabetes. Medscape Medical News
This Breast Cancer Ribbon Has a Different Take on Pink. Here’s What It Means
Landmarks around the world will light up in its colors for Breast Cancer Awareness Month.
Breast cancer patient says new type of chemo saved her life: ‘I am thriving’
A medical clinic in Scottsdale, Arizona, offers an alternative, personalized form of chemotherapy designed to target cancer cells without harming healthy cells. A woman says it saved her life.
PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancer
(MedPage Today) — The FDA approved the PI3K-pathway inhibitor inavolisib (Itovebi) for use in combination with palbociclib (Ibrance) and fulvestrant to treat locally advanced, PIK3CA-mutated, hormone receptor (HR)-positive/HER2-negative breast…
Increasing amount of breast cancer-specific death due to stage 1, 2 disease
Patients with stage I/II breast cancers have excellent prognosis, but account for more than 60 percent of breast cancer-specific death (BCSD) because of their large absolute volumes, according to a
Tirzepatide reduces obstructive sleep apnea symptoms and associated risks
1. In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was found that tirzepatide treatment reduced the occurrence of apneas and hypopneas.
‘My cancer was not in those pictures’: how breast density affects mammograms
A new FDA rule requires that screenings inform people if they have a high ratio of dense breast tissue. Experts say it’s just one step toward awarenessIn 2017, 55-year-old Leslie
Let’s Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
(MedPage Today) — As an FDA-mandated rule goes into effect requiring healthcare providers to notify women of their breast density, the American Cancer Society has an explainer on what the
Shop these pink products that support breast cancer charities
From the Estée Lauder Bouquet of Strength collection to Pretty in Pink PJs, lifestyle expert Chassie Post joins TODAY with a list of businesses that are giving back to breast
Buyer beware: Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers
In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to
Kathy Bates addresses Ozempic rumors after 100-pound weight loss: ‘This was hard work’
Kathy Bates credited both hard work and Ozempic medication for her diabetes diagnosis for helping her lose 100 pounds over a span of seven years.
STAT+: Medicare already covers GLP-1s for half of seniors with obesity, new report finds
Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.
Ozempic underworld: Inside the black market of obesity drugs
A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.
Offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget
Combination therapeutic strategy identified for triple negative breast cancer
Triple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from cancer researchers at Brigham and Women’s Hospital are pointing the way
Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to know
A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat
Weight-loss surgery may lower risk of pancreatic cancer in people with obesity
Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death rate. A new analysis in Diabetes/Metabolism Research and Reviews suggests that
Jenna Fischer Opens Up About Quietly Overcoming Breast Cancer
The star of “The Office” reminded fans how important an annual mammogram is while detailing her diagnosis and treatment in an Instagram post on Tuesday.
‘The Office’s Jenna Fischer secretly battled breast cancer, is now ‘cancer free’
Jenna Fischer was diagnosed with breast cancer last year, and celebrated with her family after recently completing surgery, chemotherapy and radiation.
“The Office” star Jenna Fischer reveals breast cancer diagnosis, treatment
“The Office” actress Jenna Fischer on Tuesday revealed that she was diagnosed with breast cancer last year but is now cancer-free after receiving treatment.
‘The Office’ Star Reveals Breast Cancer Diagnosis in Emotional Post
Bravo/GettyJenna Fischer revealed to fans Tuesday that she was diagnosed with breast cancer and has since beaten it.“Last December, I was diagnosed with Stage 1 Triple Positive Breast Cancer. After
AI could help identify women at risk for future breast cancer
Artificial intelligence (AI) scores may be able to estimate the risk for future breast cancer and lead to earlier diagnosis, according to a study published online Oct. 3 in JAMA
‘The Office’ star Jenna Fischer reveals breast cancer diagnosis
Jenna Fischer is sharing news of her breast cancer diagnosis.
DAPK3 emerges as a new regulator of migration of triple-negative breast cancer cells
Triple-negative breast cancer (TNBC) is the subtype of breast cancer that is the hardest to treat. TNBC patients account for more than 20,000 cases of this condition annually in the
Mounjaro will soon be available as a weight loss treatment on the NHS. Here’s what that means for patients
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia
(MedPage Today) — All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA’s shortage list. (Reuters)
This prompted a compounding group to
3 reasons behind the rise in breast cancer, including some you can control
There’s a troubling rise in breast cancer in women under the age of 50, an American Cancer Society report shows, but there are things you can do to help lower
Breast cancer rates rising rapidly in women under 50, new report shows
A new American Cancer Society report reveals that breast cancer rates in women under 50 have risen by 1.4% annually since 2012, double the rate seen in older women. Asian
ACS: Breast Cancer Incidence Rising, Disparities Persist
The biennial breast cancer update from the ACS reported an increase in diagnoses, especially among younger women, as well as disparities in survival outcomes. Medscape Medical News
Study finds common breast cancer treatments may speed aging process
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including chemotherapy, radiation, and surgery, may accelerate the biological
Reproductive Risk Factor Patterns in Caribbean Women With Breast Cancer
This cross-sectional study examines changes over 4 decades in factors related to reproduction in women in Caribbean countries with a diagnosis of invasive breast cancer.
Expanded Medicare Coverage of Antiobesity Drugs May Cost Billions Each Year
Expanding Medicare coverage of a glucagon-like peptide-1 (GLP-1) receptor agonist to treat obesity could increase annual spending by several billion dollars, a study in Health Affairs found.
Hormonal Contraception Linked to Increased Breast Cancer Risk in BRCA1 Carriers
(MedPage Today) — Carriers of the BRCA1 cancer gene had a significantly increased risk of breast cancer if they used hormonal contraception (HC), pooled cohort data showed.
Breast cancer
Analysis reveals higher cost of anti-obesity drugs compared to surgery
The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) exceeds that of metabolic and bariatric surgery in less than a year, according to a
With New FDA Rule, American Cancer Society Shares What Women Should Know about Breast Density
For Breast Cancer Awareness Month, the American Cancer Society highlights the importance of regular screening and informed decision-making, as dense breast tissue increases breast cancer risk and complicates mammogram detection
Weight Loss After Anti-Obesity Meds Tied to Lower Gout Risk
Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout flares in patients with overweight or obesity. Medscape Medical News
Tirzepatide Shortage Resolved? FDA Says Yes, Compounders No
Tirzepatide injection (Zepbound, Mounjaro) is officially off the FDA’s drug shortage list, meaning compounders can no longer prepare and dispense the drug. Medscape Medical News
Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved?
(MedPage Today) — As a pediatric obesity medicine specialist, I have witnessed first-hand the benefits of GLP-1 receptor agonists in the treatment of adolescent obesity. In particular, semaglutide (Wegovy) plus
Breast cancer deaths fall 44% since 1989 despite rising cases
Breast cancer rates in the United States are increasing significantly, with younger women and Asian Americans experiencing the most notable rises, according to a study released on Tuesday.
What you need to know after a breast cancer diagnosis
Breast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.
How Healthy Diet, Lifestyle May Help Lower Breast Cancer Risk as Cases Rise in Younger Women
Diet and lifestyle factors play an important role in breast cancer prevention. A&J Fotos/Getty Images
Early-onset breast cancer in females under 50 is increasing, a new report shows.
Deaths from
Do GLP-1 Supplements Work? Doctors Set the Record Straight on ‘Nature’s Ozempic’
Brands like Kourtney Kardashian’s Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, and Mounjaro. But the truth is, these supplements have little to nothing
Obesity is falling for the first time as Ozempic and weight loss drugs rise
Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with the rise of Ozempic and other popular weight loss
Clinical trial finds new drug significantly extends lives of breast cancer patients
Patients with advanced HER2-positive breast cancer very often develop brain metastases. When this happens, patients have low chances of surviving the next few years with existing therapies such as surgery
Trial to diagnose breast cancer more quickly
A scheme to let women with symptoms book an appointment directly with a clinic is being trialled.
Ozempic for all, Zepbound is back, and the top CEO pay: Pharma news roundup
The mayor of Rio de Janeiro is promising to make a generic version of Ozempic available through the city’s public health network — if he wins reelection. The top 5
Fall River Eats: Galley Grille, Bally’s promos to help breast cancer care, research
Commercial AI tools can be used to predict breast cancer risk, need for extra screening
Researchers find tools developed for diagnosis can result in early detection of the disease, ensuring better prognosis Commercial artificial intelligence (AI) based tools developed for the detection of breast cancer
Study ties diabetes and obesity to increased risk of liver cancer relapse
Hepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal. Recent advances in antiviral therapy have reduced the
A mayor promises Ozempic for all and says there ‘will be no more fat people’ in his city
A Brazilian politician is making an interesting campaign pitch: Ozempic for all.Read more…
Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).Read more…
Balancing health: diabetes and obesity increase risk of liver cancer relapse
A research team analyzed how diabetes mellitus and obesity factor into recurrence and survival after surgery for hepatocellular carcinoma, a type of liver cancer.
TDXd Better Than Chemo for HER2-Low Breast Cancer?
Trial results suggested the antibody-drug conjugate may be a treatment option for patients with HER2 metastatic breast cancer in whom endocrine-based therapy has failed. Medscape Medical News
US breast cancer deaths fall but younger women increasingly diagnosed – study
Report shows significantly improved survival rates but a steep increase in disease among women younger than 50A new report from the American Cancer Society (ACS) finds that breast cancer deaths
Breast cancer spikes among women under 50, plus healthy foods that are high in calories
The Fox News Health Newsletter brings you trending and important stories about health care, drug developments, mental health issues, real people’s triumphs over medical struggles, and more.
Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection
This cohort study examines whether a commercial artificial intelligence algorithm for breast cancer detection could estimate the development of cancer years before diagnosis.
3 More Benefits GLP-1 Drugs Like Ozempic May Provide in Addition to Weight Loss
New research suggests GLP-1 medications like Ozempic may help lower several health risks in addition to treating type 2 diabetes and obesity. Igor Alecsander/Getty Images
GLP-1 medications are most often
Ozempic’s cousin drug liraglutide is about to get cheaper. But how does it stack up?
Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is sold under the brand names Victoza and Saxenda.
Beyonce’s Dad, Mathew Knowles, Details His Journey to Become a Breast Cancer Survivor
Beyonce’s father, Mathew Knowles, is sharing the details of his breast cancer journey to help raise awareness about the early signs he noticed, the importance of screenings, and how he
STAT+: ResMed CEO on how wearables, GLP-1s will impact sleep apnea device sales
Leading CPAP device maker ResMed’s CEO Mick Farrell sees ‘two tidal waves’ of innovation driving more people to the company’s devices.
Breast cancer-linked chemicals found in food packaging: Safety tips from experts
American Cancer Society report finds rise in breast cancer cases in younger women
A new report released by the American Cancer Society reveals that breast cancer diagnoses are on the rise, especially among younger women and Asian American women.. NBC News medical contributor
HS Symptoms Eased by Semaglutide-Aided Weight Loss
Improvements in the Dermatology Life Quality Index score and hidradenitis suppurativa flares were seen in people who achieved semaglutide-induced weight loss. Medscape Medical News
Radiation oncologist on latest breast cancer therapies, treatments
Dr. Marisa Weiss, radiation oncologist and founder of breastcancer.org, shares the questions women should ask after being diagnosed with breast cancer, what to know about the latest treatments, how to
Inside the push to create a safe, effective vaccine for breast cancer
Kristen Dahlgren, founder of research non-profit The Cancer Vaccine Coalition, along with NBC News medical contributor Dr. Natalie Azar, join TODAY to break down the emerging breast cancer vaccine trials
Trump Vows to Veto Abortion Ban; Breast Cancer Climbs; Diagnostic Errors for 1 in 14
(MedPage Today) — Note that some links may require registration or subscription.
Former president Donald Trump vowed to veto a federal abortion ban if re-elected. (Politico)
Vice President
Breast cancer signs, symptoms to look out for, plus when to schedule routine screening
Breast cancer is a common type of cancer found in women. One measure women take to screen for the disease is getting routine mammograms.
Breast cancer diagnoses spiking among women under 50, new report reveals
Although breast cancer deaths have been declining for decades in the U.S., diagnoses have been on the uptick among women 50 and younger, according to a new report from the
GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy
Food left in the stomach or stool left in the bowel can impede a doctor’s ability to successfully perform an endoscopy or colonoscopy.
No Improvement in Lymphedema With Hypofractionated Nodal RT for Breast Cancer
(MedPage Today) — Hypofractionated lymph node irradiation failed to reduce the frequency of lymphedema after treatment for invasive breast cancer, a randomized trial showed.
A 3-week radiation therapy (RT)
GLP-1s like Ozempic are now more popular than insulin for treating diabetes
It took GLP-1 medications like Ozempic just seven years to surpass insulin as the the second most common treatment for type 2 diabetes, according to a new report by the
Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers
Newly diagnosed breast cancer patients often experience such symptoms as fatigue, depression and poor sleep quality, even before treatments such as chemotherapy and radiation. However, recommendations for managing symptoms often
Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy
(MedPage Today) — Patients on GLP-1 receptor agonists had a low risk of food retention when an esophagogastroduodenoscopy (EGD) was combined with a colonoscopy, a small retrospective study found.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
The American Cancer Society (ACS) has released Breast Cancer Statistics, 2024, the organization’s biennial update on breast cancer occurrence and trends in the United States.